More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.
Ozempic and Wegovy are both semaglutides or GLP-1 drugs, made by different brands, but they “are identical,” Messer says. Their slight difference is in their dosage. “The max dose of Ozempic ...
The popular anti-obesity drug Mounjaro has finally been launched in India. The development comes after Eli Lilly received ...
Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...
The widely used anti-diabetes and weight loss drug Mounjaro, which contains the active ingredient tirzepatide, is now ...
The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...
Offering a dual-action mechanism targeting GLP-1 and GIP receptors, it has shown potential benefits over Ozempic and is now available in India at a significantly lower cost. Ozempic is old school.